New publications from WG4

Home
New publications from WG4

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

šŸš€Ā Exciting News from working group 4 of IMMUNO-model!Ā šŸ§¬

Weā€™re proud to announce the publication ofĀ four comprehensive review articlesĀ fromĀ Working Group 4, supported by theĀ IMMUNO-modelĀ project! These articles explore key advancements in Cancer Immunity and Immunotherapy, contributing valuable insights to the scientific community.

šŸ“š Dive into the research:

1ļøāƒ£Ā Unleashing the power of CAR-M therapy in solid tumors: a comprehensive review
šŸ”— https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1615760/full
2ļøāƒ£Ā Challenges in the preclinical design and assessment of CAR-T cells
šŸ”— https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1564998/abstract
3ļøāƒ£Ā CAR-NK cells: harnessing the power of natural killers for advanced cancer therapy
šŸ”— https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1603757/full
4ļøāƒ£Ā Tumor-infiltrating lymphocytes in cancer immunotherapy: from chemotactic recruitment to translational modeling
šŸ”— https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1601773/full

Latest Updates

view all
STSMITCDCVMYRI

Second Grant Call Opens on 1st May 2026 until 1st October 2026!

STSM: Short Term Scientific Mission Visit to a host organization located in a different country than the country of affiliation by a researcher or innovator for specific work to be...
Read More
Patients Webinars

IMMUNO-model webinar series presents: 11th Webinar

Patientsā€™ Webinar: Immunotherapy in Cancer ā€“ How It Works and Why Challenges Remain April 23rd, at 4 pm CETLive on TEAMs platform Speakers Dr. Uzma Hassan, CRCL ā€“ The Lyon...
Read More
Workshop

Workshop – Models, Challenges And Promises Of Advanced Therapies For Cancer: Nk Cells In The Clinic And Industry

The @immunomodel COST Action workshop MODELS, CHALLENGES AND PROMISES OF ADVANCED THERAPIES FOR CANCER: NK CELLS IN THE CLINIC AND INDUSTRY, organized by @MarValesLab CNB-CSIC, brought together leading international experts...
Read More
News

Annual Report GP3

IMMUNO-model released Annual report for Grant Period 3, in which activities and achievements of IMMUNO-model are summarized
Read More
Webinar Series

Patient Webinar: Immunotherapy in Cancer ā€“ How It Works and Why Challenges Remain

We invite cancer patients, relatives, and caregivers to join our patient webinar, where we will explain the basics of immunotherapy, discuss current challenges, and highlight how patient involvement is essential...
Read More
Knowledge Hub

ā€œInvasion/Chemotaxis-on-chipā€ by Devrim Pesen Okvur

Weā€™re excited to share the latest addition to the IMMUNOmodel Knowledge Hub:šŸ‘‰ ā€œInvasion/Chemotaxis-on-chipā€ by Devrim Pesen OkvuršŸ”—Ā https://osf.io/yws9r/files/7sqyeĀ  This step-by-step protocol details how to study cell invasion and chemotaxis in 3D...
Read More

Join us

How to Participate

The COST Action IMMUNO-model welcomes research-active scientists working in the field.

How to Get Involved

  • Read the Project DescriptionĀ MoU;
  • Ā Inform the Main Proposer/Chair of your interest (email);
  • ApplyĀ to join your Working Groups of interest;
  • You will be informed by the working group leaders as soon as your application has been reviewed;
  • Please note, Management Committee nominations are carried out through the COST National Contact Points.

How to participate in an existing Action?

If you would like to join this COST Action please ensure that you read the guidance notes published on the COST website. You can find full documentation regarding general rules and guidelines for COST Actions atĀ www.cost.eu/participate.

Know more about Cost actions

Subscribe to our newsletter